Inmune Bio INMB Growth Metrics (2018-2026)

NASDAQ INMB
$1.96 -0.04 (-2.00%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Inmune Bio Quarterly Growth Metrics

Periods 34 quarters
Latest Jun 2026

Inmune Bio reported asset growth of -28.76% for the quarter ended Jun 2026. These growth metrics cover 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
151.47%145.83%43.23%44.66%-22.17%-18.16%-21.59%-20.60%-25.18%-30.31%-36.69%-24.77%-15.82%-30.59%-19.29%-28.16%-36.80%-18.23%-31.70%-28.76%
Assets Growth (3y)
79.22%58.61%47.20%48.88%49.52%46.19%44.63%13.56%11.92%-10.75%-4.75%-21.15%-26.58%-26.28%-24.57%-26.44%-26.60%-29.59%-27.25%
Assets Growth (5y)
34.75%26.84%14.65%13.76%15.76%10.08%9.81%10.33%-4.87%-4.47%-17.08%-15.06%
Assets (QoQ)
77.38%-7.18%-5.60%-6.94%-4.57%-2.39%-9.56%-5.76%-10.07%-9.09%-17.84%12.00%0.63%-25.05%-4.45%-0.31%-11.48%-3.02%-20.19%3.98%
Capital Expenditures (QoQ)Capex (QoQ)
-25.91%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
247.46%240.56%47.17%54.89%-32.04%-30.29%-23.57%-21.87%-27.16%-31.26%-49.02%-35.04%-19.76%-41.64%-25.63%7.42%-17.34%18.30%10.45%-44.83%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
406.30%637.89%122.61%86.98%98.11%95.35%104.88%114.94%19.81%17.73%-16.92%-7.71%-26.49%-34.60%-33.83%-18.31%-21.53%-22.00%-25.19%-27.25%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
107.05%91.97%112.32%129.91%186.35%33.86%27.11%35.36%24.49%26.66%47.28%2.67%2.42%-13.98%-14.17%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
113.74%-11.44%-10.80%-8.27%-6.22%-9.15%-2.21%-6.23%-12.57%-14.27%-27.47%19.49%7.99%-37.64%-7.58%72.59%-16.90%-10.76%-13.71%-13.80%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
25.91%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-114.25%-308.86%-74.10%16.64%57.50%41.77%87.13%33.31%-26.64%39.93%-555.21%-148.46%-63.84%-223.06%8.72%6.48%22.14%73.20%50.13%56.65%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-160.16%-176.55%-85.55%-43.28%-20.06%-135.98%-3.30%-20.41%-4.86%-12.67%-13.66%-11.37%4.11%-4.16%8.35%-15.72%-17.33%19.58%-43.94%-0.24%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-28.25%-31.16%-56.80%-49.22%-40.05%-37.27%-29.13%-91.12%-45.82%-32.32%-8.02%-4.37%7.74%10.95%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-38.78%-23.44%9.36%46.32%29.25%-69.14%79.96%-178.18%-34.34%19.77%-118.53%-5.48%11.41%-58.20%38.26%-8.07%26.25%45.54%-14.89%6.05%
EBIT Growth (1y)
-87.16%-181.40%-42.44%2.53%17.49%37.52%0.85%-0.36%-14.58%-48.51%-71.52%-53.88%-44.07%-12.98%10.09%-149.07%39.50%42.18%41.32%93.99%
EBIT Growth (3y)
-80.27%-68.73%-50.22%-146.13%-34.13%-34.24%-45.34%-44.91%-20.95%-37.70%-34.30%-14.60%-10.85%-1.59%-15.20%-56.68%0.04%1.00%3.28%38.71%
EBIT Growth (5y)
-17.68%-0.76%-40.82%-34.84%-41.96%-87.26%-31.84%-32.34%-36.48%-63.44%-9.05%-11.27%-5.03%25.78%
EBIT Margin Growth (1y)
10.97M5.68M-0.03M-1.29M2.60M-1.22M-2.41M-6.18M5.89M
EBIT Margin Growth (3y)
3.50M-1.58M
EBIT Margin (QoQ)
5.89M0.16M-3.60M3.23M0.18M-1.11M0.30M-0.59M-1.01M-4.88M
EBIT (QoQ)
-37.64%-0.10%28.26%1.39%-16.52%24.20%-13.84%0.19%-33.02%1.75%-31.48%10.46%-24.54%22.94%-4.63%-148.07%69.75%26.36%-6.17%74.60%
EBT Growth (1y)
-87.16%-181.40%-42.44%2.53%17.49%37.52%0.85%-0.36%-14.58%-48.51%-71.52%-53.88%-44.07%-12.98%10.09%-149.07%39.50%42.18%41.32%93.99%
EBT Growth (3y)
-80.27%-68.73%-50.48%-153.51%-34.38%-34.51%-45.85%-44.91%-20.95%-37.70%-34.30%-14.60%-10.85%-1.59%-15.20%-56.68%0.04%1.00%3.28%38.71%
EBT Growth (5y)
-17.68%-0.76%-40.82%-34.84%-42.11%-90.61%-31.99%-32.50%-36.76%-63.44%-9.05%-11.27%-5.03%25.78%
EBT Margin Growth (1y)
10.97M5.68M-0.03M-1.29M2.60M-1.22M-2.41M-6.18M5.89M
EBT Margin Growth (3y)
3.50M-1.58M
EBT Margin (QoQ)
5.89M0.16M-3.60M3.23M0.18M-1.11M0.30M-0.59M-1.01M-4.88M
EBT (QoQ)
-37.64%-0.10%28.26%1.39%-16.52%24.20%-13.84%0.19%-33.02%1.75%-31.48%10.46%-24.54%22.94%-4.63%-148.07%69.75%26.36%-6.17%74.60%
EPS (Basic) Growth (1y)
-49.57%-124.33%-21.44%14.26%21.13%45.73%5.72%4.93%-10.46%-43.72%-67.93%-39.35%-25.99%0.97%29.22%-107.96%59.36%54.36%53.02%95.46%
EPS (Basic) Growth (3y)
-45.66%-40.39%-24.02%-114.47%-14.74%-12.97%-23.66%-22.89%-9.23%-20.50%-24.35%-4.34%-3.16%8.25%-3.87%-40.19%17.30%13.39%17.65%49.14%
EPS (Basic) Growth (5y)
-1.80%12.54%-21.91%-16.63%-24.74%-67.20%-16.02%-15.46%-17.58%-40.00%7.78%4.58%8.56%36.02%
EPS (Basic) (QoQ)
-22.81%-9.85%35.57%1.36%-12.97%24.41%-11.94%0.54%-31.26%1.66%-30.79%17.47%-18.68%22.70%6.52%-142.49%76.81%13.17%3.78%76.57%
EPS (Diluted) Growth (1y)
21.13%45.73%5.72%4.93%-10.46%-43.72%-67.93%-39.35%-25.99%0.97%29.22%-107.96%59.36%54.36%53.02%95.46%
EPS (Diluted) Growth (3y)
-3.16%8.25%-3.87%-40.19%17.30%13.39%17.65%49.14%
EPS (Diluted) (QoQ)
-9.85%35.57%1.36%-12.97%24.41%-11.94%0.54%-31.26%1.66%-30.79%17.47%-18.68%22.70%6.52%-142.49%76.81%13.17%3.78%76.57%
FCF Margin Growth (1y)
12.19M5.32M0.01M0.24M2.28M-0.65M-0.63M-5.04M3.98M
FCF Margin Growth (3y)
7.39M-0.82M
FCF Margin (QoQ)
5.06M0.06M-2.43M2.63M-0.24M0.29M-0.39M-0.30M-0.23M-4.12M
Free Cash Flow Growth (1y)FCF Growth (1y)
-114.25%-308.86%-74.10%16.64%57.50%41.77%87.13%33.31%-26.64%39.93%-555.21%-148.46%-63.84%-223.06%8.72%6.48%19.38%71.91%50.13%56.65%
Free Cash Flow Growth (3y)FCF Growth (3y)
-160.16%-176.55%-85.55%-43.28%-20.06%-135.98%-3.30%-20.41%-4.86%-12.67%-13.66%-11.37%4.11%-4.16%8.35%-15.72%-18.71%18.31%-43.94%-0.24%
Free Cash Flow Growth (5y)FCF Growth (5y)
-28.25%-31.16%-56.80%-49.22%-40.05%-37.27%-29.13%-91.12%-45.82%-32.32%-8.78%-5.36%7.74%10.95%
Free Cash Flow (QoQ)FCF (QoQ)
-38.78%-23.44%9.36%46.32%29.25%-69.14%79.96%-178.18%-34.34%19.77%-118.53%-5.48%11.41%-58.20%38.26%-8.07%23.63%44.87%-9.60%6.05%
Net Cash Flow Growth (1y)NCF Growth (1y)
130.37%-308.86%-134.81%-151.49%-107.48%41.77%85.98%33.31%-26.64%-3.97%-774.32%261.03%165.81%-121.75%84.46%191.45%-300.71%76.86%-119.55%-121.46%
Net Cash Flow Growth (3y)NCF Growth (3y)
367.32%-176.55%-50.19%-50.73%-20.06%-135.98%-3.01%-40.11%-30.42%-35.27%-34.38%-17.92%-60.35%-10.32%42.46%72.47%-18.71%18.90%-43.94%-0.24%
Net Cash Flow Growth (5y)NCF Growth (5y)
-31.94%-31.16%-56.80%-66.53%-29.92%8.88%28.05%-97.83%-8.22%71.67%-18.00%-4.90%-16.50%-18.59%
Net Cash Flow (QoQ)NCF (QoQ)
387.11%-121.72%16.81%41.51%29.25%-69.14%79.96%-178.18%-34.34%-38.86%-68.49%151.23%-45.10%-567.93%88.19%1,061.03%-137.81%46.06%-12.01%6.05%
Net Income Growth (1y)
-87.16%-181.40%-51.51%2.53%17.49%37.52%6.95%-0.36%-14.58%-48.51%-71.52%-53.88%-44.07%-12.98%10.09%-149.07%39.50%42.18%41.32%93.99%
Net Income Growth (3y)
-80.27%-68.73%-53.70%-153.51%-34.38%-34.51%-45.85%-44.91%-20.95%-37.70%-34.22%-14.60%-10.85%-1.59%-12.79%-56.68%0.04%1.00%3.28%38.71%
Net Income Growth (5y)
-17.68%-0.76%-40.82%-34.84%-42.11%-90.61%-31.99%-32.50%-36.76%-63.44%-9.05%-11.27%-4.99%25.78%
Net Income (QoQ)
-37.64%-0.10%23.55%7.46%-16.52%24.20%-13.84%0.19%-33.02%1.75%-31.48%10.46%-24.54%22.94%-4.63%-148.07%69.75%26.36%-6.17%74.60%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-100.51%-201.84%-51.51%-2.75%18.32%39.69%5.32%4.93%-10.85%-44.15%-68.68%-49.92%-41.22%-9.85%11.66%-150.95%46.48%43.34%44.48%94.80%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-83.14%-72.63%-53.70%-159.33%-36.06%-36.01%-46.71%-45.56%-21.99%-37.93%-34.26%-13.56%-8.54%1.52%-12.16%-52.93%5.73%3.55%6.13%41.93%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-18.09%-1.04%-40.94%-34.93%-42.13%-90.15%-31.57%-31.85%-36.30%-63.27%-6.53%-10.31%-3.48%28.17%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-42.12%-2.25%28.62%0.94%-12.97%24.49%-12.05%0.54%-31.72%1.81%-31.13%11.60%-24.08%23.63%-5.45%-151.13%73.54%19.14%-3.33%76.46%
Net Margin Growth (1y)
10.97M5.97M-0.01M-1.30M2.86M-1.20M-2.40M-6.16M5.93M
Net Margin Growth (3y)
3.52M-1.52M
Net Margin (QoQ)
6.16M0.17M-3.85M3.49M0.19M-1.12M0.31M-0.58M-1.01M-4.87M
Operating Income Growth (1y)Op. Inc Growth (1y)
-87.16%-181.40%-42.44%2.53%17.49%37.52%0.85%-0.36%-14.58%-48.51%-71.52%-53.88%-44.07%-12.98%10.09%-149.07%39.50%42.18%41.32%93.99%
Operating Income Growth (3y)Op. Inc Growth (3y)
-80.27%-68.73%-50.22%-146.13%-34.13%-34.24%-45.34%-44.91%-20.95%-37.70%-34.30%-14.60%-10.85%-1.59%-15.20%-56.68%0.04%1.00%3.28%38.71%
Operating Income Growth (5y)Op. Inc Growth (5y)
-17.68%-0.76%-40.82%-34.84%-41.96%-87.26%-31.84%-32.34%-36.48%-63.44%-9.05%-11.27%-5.03%25.78%
Operating Income (QoQ)Op. Inc (QoQ)
-37.64%-0.10%28.26%1.39%-16.52%24.20%-13.84%0.19%-33.02%1.75%-31.48%10.46%-24.54%22.94%-4.63%-148.07%69.75%26.36%-6.17%74.60%
Operating Margin Growth (1y)
10.97M5.68M-0.03M-1.29M2.60M-1.22M-2.41M-6.18M5.89M
Operating Margin Growth (3y)
3.50M-1.58M
Operating Margin (QoQ)
5.89M0.16M-3.60M3.23M0.18M-1.11M0.30M-0.59M-1.01M-4.88M
Profit After Tax Growth (1y)PAT Growth (1y)
-87.16%-181.40%-42.44%2.53%17.49%37.52%0.85%-0.36%-14.58%-48.51%-71.52%-53.88%-44.07%-12.98%10.09%-149.07%39.50%42.18%41.32%93.99%
Profit After Tax Growth (3y)PAT Growth (3y)
-80.27%-68.73%-50.48%-153.51%-34.38%-34.51%-45.85%-44.91%-20.95%-37.70%-34.30%-14.60%-10.85%-1.59%-15.20%-56.68%0.04%1.00%3.28%38.71%
Profit After Tax Growth (5y)PAT Growth (5y)
-17.68%-0.76%-40.82%-34.84%-42.11%-90.61%-31.99%-32.50%-36.76%-63.44%-9.05%-11.27%-5.03%25.78%
Profit After Tax (QoQ)PAT (QoQ)
-37.64%-0.10%28.26%1.39%-16.52%24.20%-13.84%0.19%-33.02%1.75%-31.48%10.46%-24.54%22.94%-4.63%-148.07%69.75%26.36%-6.17%74.60%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
78.75%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
24.36%8.77%-5.45%39.76%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
664.00115.00-485.00-417.00-696.00-376.00-82.00-166.00-610.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M-0.00M-733.00-106.00-65.00486.00-643.00-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
252.00-37.00-434.00-198.00-28.00283.00-139.00-283.00-471.00-891.00-0.00M-999.00-284.00-0.00M-0.00M-0.00M435.0041.00-462.000.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
669.00129.00-434.00-309.00-779.00-679.00-521.00-927.00-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.00M-903.00-410.00-373.00-66.00-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.02M-0.01M-0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
233.008.00-378.00-172.00-236.00108.00-220.00-578.00-799.00-0.00M-0.00M-962.00215.00-236.00-0.00M-0.01M0.00M-0.00M0.00M0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
48.00-409.00-0.00M-722.00-904.00-799.00-445.00-587.00-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M0.01M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M0.00M-0.00M-0.00M-0.00M-0.00M-555.00-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.01M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
-3.00-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.02M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ)
34.0088.00-581.00-263.00-148.00194.00-227.00-405.00-817.00-0.00M-0.00M-0.00M631.00-963.00-0.00M-0.01M268.00-437.00-687.000.01M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
10.97M43.84M5.68M-0.03M-1.29M2.60M-1.22M-2.41M-6.18M-3.05M-7.91M-27.46M5.89M-6.80M-0.38M20.98M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
3.50M43.38M-3.45M-29.90M-1.58M-7.25M-9.52M-8.89M
Return on Sales [ROS] (QoQ)ROS (QoQ)
41.38M5.89M0.16M-3.60M3.23M0.18M-1.11M0.30M-0.59M-1.01M-4.88M3.42M-5.45M-20.56M28.47M-9.26M0.97M0.80M
Revenue Growth (1y)
3,975.00%600.00%-40.49%-76.69%187.50%-56.12%-71.13%-63.16%257.14%
Revenue Growth (3y)
51.83%-32.56%
Revenue (QoQ)
1,064.29%0.00%-90.18%512.50%-1.02%-60.82%21.05%-6.52%-34.88%-50.00%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
53.59%116.50%70.86%147.07%18.31%14.91%13.09%0.00%0.00%7.43%3.63%22.58%-9.53%-6.49%15.33%-34.13%73.59%88.73%-27.89%-11.47%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
17.92%16.81%16.37%24.92%24.92%14.26%36.56%40.78%22.03%38.78%26.04%44.68%2.29%4.90%10.56%-6.88%16.24%23.77%-4.84%-10.59%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
-6.73%-19.46%14.17%14.50%13.05%19.03%12.02%8.43%24.94%17.63%23.33%36.37%10.74%12.05%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
108.84%-5.23%0.92%23.70%0.00%-7.95%-0.69%9.38%0.00%-1.11%-4.20%29.39%-26.19%2.21%18.16%-26.11%94.52%11.13%-54.86%-9.29%
Total Debt Growth (1y)
1.55%1.58%1.65%1.72%1.72%-15.40%-32.50%1.29%-32.67%-59.65%
Total Debt Growth (3y)
-11.40%-29.74%
Total Debt (QoQ)
0.37%0.40%0.39%0.39%0.40%0.46%0.46%0.39%-16.50%-19.84%50.74%-33.27%-49.95%

Inmune Bio Growth Metrics API

Pull Inmune Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INMB&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY